Comorbidity of substance misuse and mental illness in community mental health and substance misuse services

T. WEAVER ; P. MADDEN ; V. CHARLES ; G. STIMSON ; A. RENTON ; P. TYRER ; T. BARNES ; C. BENCH ; MIDDLETON H. ; N. WRIGHT ; S. PATERSON ; W. SHANAHAN ; N. SEIVEWRIGHT ; C. FORD ; COMORBIDITY OF SUBSTANCE MISUSE AND MENTAL ILLNESS COLLABORATIVE STUDY TEAM | 2003
Dans British Journal of Psychiatry (Vol.183, n°4, October 2003) Article : Périodique

BACKGROUND: Improved management of mental illness and substance misuse comorbidity is a National Health Service priority, but little is known about its prevalence and current management. AIMS: To measure the prevalence of comorbidity among pat[...]

Plus d'info

Ajouter à la sélection

Homeless drug users' awareness and risk perception of peer "Take Home Naloxone" use - a qualitative study

N. WRIGHT ; OLDHAM N. ; K. FRANCIS ; L. JONES | 2006
Dans Substance Abuse Treatment, Prevention, and Policy (Vol.1, n°28, 2006) Article : Périodique

Background: Peer use of take home naloxone has the potential to reduce drug related deaths. There appears to be a paucity of research amongst homeless drug users on the topic. This study explores the acceptability and potential risk of peer use [...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]

J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]

Plus d'info

Ajouter à la sélection

A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users

N. WRIGHT ; C. TOMPKINS | 2006
Périodique

FRANÇAIS : Cette revue de la littérature a pour but de déterminer l'efficacité des actions de prévention primaire de l'hépatite C chez les usagers de drogues injectables. L'analyse des résultats des études recensées montre que les différents ty[...]

Plus d'info

Ajouter à la sélection

The Dedicated Drug Courts pilot evaluation process study

J. KERR ; C. TOMPKINS ; W. TOMASZEWSKI ; S. DICKENS ; R. GRIMSHAW ; N. WRIGHT ; M. BARNARD | 2011
Rapport

Aim: To examine the implementation of six pilot Dedicated Drug Courts (DDCs) dealing with drug misusing offenders, which were introduced to magistrates' courts in England and Wales from 2004. To look at the DDCs' potential for reducing drug us[...]

Plus d'info

Ajouter à la sélection

Lien externe